van Laar JM - Search Results

1

Bronchiolitis obliterans organizing pneumonia after adjuvant radiotherapy for breast carcinoma.

van Laar JM, Holscher HC, van Krieken JH, Stolk J. van Laar JM, et al. Among authors: van krieken jh. Respir Med. 1997 Apr;91(4):241-4. doi: 10.1016/s0954-6111(97)90046-9. Respir Med. 1997. PMID: 9156149 Free article. No abstract available.

2

Severe hepatitis and pure red cell aplasia in adult Still's disease: good response to immunosuppressive therapy.

Janssen HL, van Laar JM, van Hoek B, den Ottolander GJ, van Krieken JH, Breedveld FC. Janssen HL, et al. Among authors: van hoek b, van krieken jh, van laar jm. Dig Dis Sci. 1999 Aug;44(8):1639-42. doi: 10.1023/a:1026631514623. Dig Dis Sci. 1999. PMID: 10492146

3

Scleroderma lung: pathogenesis, evaluation and current therapy.

van Laar JM, Stolk J, Tyndall A. van Laar JM, et al. Drugs. 2007;67(7):985-96. doi: 10.2165/00003495-200767070-00004. Drugs. 2007. PMID: 17488144 Review.

4

Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis.

Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, van der Giesen FJ, de Jong Z, Stolk J, Voskuyl AE, Scherptong RW, van Laar JM, Schuerwegh AJ, Huizinga TW, Vlieland TP. Schouffoer AA, et al. Among authors: van der giesen fj, van laar jm. Arthritis Care Res (Hoboken). 2011 Jun;63(6):909-17. doi: 10.1002/acr.20448. Arthritis Care Res (Hoboken). 2011. PMID: 21312348 Free article. Clinical Trial.

5

Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases.

Chiu YH, Spierings J, de Jong PA, Hoesein FM, Grutters JC, van Laar JM, Voortman M. Chiu YH, et al. Among authors: van laar jm. Respir Med. 2021 Oct;187:106579. doi: 10.1016/j.rmed.2021.106579. Epub 2021 Aug 18. Respir Med. 2021. PMID: 34438351 Free article.

6

Heart failure as presenting manifestation of cardiac involvement in systemic lupus erythematosus.

van der Laan-Baalbergen NE, Mollema SA, Kritikos H, Schoe A, Huizinga TW, Bax JJ, Boumpas DT, van Laar JM. van der Laan-Baalbergen NE, et al. Among authors: van laar jm. Neth J Med. 2009 Oct;67(9):295-301. Neth J Med. 2009. PMID: 19841486 Free article.

7

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP; focuSSced investigators. Khanna D, et al. Among authors: van laar jm. Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.

8

A Dutch consensus statement on the diagnosis and treatment of ANCA-associated vasculitis.

Dirikgil E, Tas SW, Rutgers A, Verhoeven PMJ, van Laar JM, Hagen EC, Tekstra J, L Hak AE, van Paassen P, Kok MR, Goldschmeding R, van Dam B, Douma CE, Remmelts HHF, Sanders JF, Jonker JT, Rabelink TJ, Damoiseaux JGMC, Bernelot Moens HJ, J W Bos W, Teng YKO. Dirikgil E, et al. Among authors: van dam b, van paassen p, van laar jm. Neth J Med. 2020 Mar;78(2):71-82. Neth J Med. 2020. PMID: 32332176 Free article.

9

Rheumatoid vasculitis presenting as appendicitis.

van Laar JM, Smit VT, de Beus WM, Collée G, Jansen EH, Breedveld FC. van Laar JM, et al. Clin Exp Rheumatol. 1998 Nov-Dec;16(6):736-8. Clin Exp Rheumatol. 1998. PMID: 9844770

10

T cell vaccination in humans: the experience in rheumatoid arthritis.

van Laar JM, de Vries RR, Breedveld FC. van Laar JM, et al. Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S59-62. Clin Exp Rheumatol. 1993. PMID: 8324953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

325 results

Search Page